Founded in 2007, AustinPx is a fee-for-service CDMO offering preclinical through Phase II formulation and process development and GMP manufacturing of oral dosage forms. We specialize in bioavailability enhancement, speed to clinic and market development strategies, and dose form development.

The name AustinPx represents where we come from and what we do. Px stands for Pharmaceutics. To our core, we are a pharmaceutics company. Our approach is data-driven and agnostic which means our formulation strategy for each drug is based on the unique physiochemistry of that compound. And for poorly soluble compounds, we have one of the most powerful tools available in KinetiSol®, a truly next generation technology for rendering active pharmaceutical ingredients amorphous.

Our services include:

• Preclinical Development
• Formulation Development
• Analytical
• GMP Manufacturing
• Bioavailability Enhancement
• Speed to Clinic and Market Strategies

Why AustinPx?

Better Solutions. Better Service.

• Flexible and responsive: In the fast-paced environment of early development, we have built our culture and systems for flexibility and responsiveness. From shifting API delivery dates to changing clinical targets, we empathize with your needs and adapt to changing requirements.
• Solutions driven: Our teams are driven by data and solving problems. We hire intelligent individuals with strong communication skills, arm them with tools necessary to make informed decisions, and empower them to partner with our clients to define the best path forward.
• Consultative and unbiased: Every company and molecule are unique. We partner with our clients to understand their challenges and goals, then design a project plan tailored to their needs. Our goals are to provide data-driven recommendations and never tie you to a platform technology.

KinetiSol™ Technology

The KinetiSol Technology generates amorphous solid dispersions (ASD), dramatically improving the bioavailability of poorly soluble drugs. KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies- in a fraction of the time of other ASD technologies. With its significantly smaller ecological footprint, broader formulation design space, faster processing times and wider applications to challenging molecules, KinetiSol is the next generation amorphous dispersion technology.